20.12.2016
- Proteros Biostructures has entered into a second research agreement with Merck Sharp & Dohme (known as MSD outside the US and Canada). The new collaboration is aimed at developing...
07.05.2015
- An investment in process analytical technology (PAT) is not just a capital investment, but also an investment in human resources and a commitment to change fundamental processes...
28.10.2013
- Potential For Success - There is great promise for innovative R&D, generics and active pharmaceutical ingredient (API) manufacture in Russia and the countries that make up Central...
19.04.2011
- Merck & Co., known as MSD outside the United States and Canada, announced the commencement of the tender offer for all outstanding shares of Inspire Pharmaceuticals, Inc. for $5.00...
